evel of lactoferrin in oral lichen planus and oral lichenoid lesions undergoing topical steroid therapy

Faculty of Dentistry, Chulalongkorn University0 个研究点目标入组 15 人开始时间: 2020年7月23日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Oral lichen planus patients (OLP) with severity evaluated according to Thongprasom scoring system as score 3, 4 or 5.
•2. OLP patients have not used a topical steroid before participating in this study.
•3. OLP patients are treated with 0.1% FAO applied 3 times daily for 3 months during the investigation.
•4. Participants have no signs of oral candidiasis at the beginning of the study.
•5. Participants have no history of treatment with chemotherapy or radiotherapy.
•6. Participants have no signs of dry mouth.
•7. Participants have no history of any disease or medical condition predisposing them to oral candidiasis.
•8. Participants have no history of taking antifungal agents, using an antiseptic mouthwash, or smoking for at least 1 month.

•1. Participants use antifungal agents during the investigation time.
•2. To change in type or preparation of topical steroid treatment during the investigation time.
•3. Participants would like to withdraw from the research project.

发起方

Faculty of Dentistry, Chulalongkorn University